It has been shown that AUR enhanced the accumulation of daunorubicin, a p-glycoprotein substrate, in multidrug-resistant human cervical carcinoma cells by competitively interacting with the drug-binding site of p-glycoprotein (32). This evidence concerns the gene ABCB1 and cervical carcinoma.